Simplex Trading’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,698
| Closed | -$13.4K | – | 9858 |
|
|
2026
Q1 | $15.3K | Buy |
+9,698
| New | +$16.4K | ﹤0.01% | 6977 |
|
|
2025
Q4 | – | Sell |
-28,017
| Closed | -$47K | – | 9373 |
|
|
2025
Q3 | $47K | Buy |
+28,017
| New | +$33.2K | ﹤0.01% | 6514 |
|
|
2025
Q1 | – | Sell |
-351
| Closed | -$206 | – | 9120 |
|
|
2024
Q4 | $0 | Sell |
351
-1,099
| -76% | -$807 | ﹤0.01% | 9127 |
|
|
2024
Q3 | $1K | Sell |
1,450
-1,405
| -49% | -$1.3K | ﹤0.01% | 8206 |
|
|
2024
Q2 | $2K | Sell |
2,855
-3,444
| -55% | -$3.8K | ﹤0.01% | 8298 |
|
|
2024
Q1 | $9K | Sell |
6,299
-3,257
| -34% | -$3.69K | ﹤0.01% | 7682 |
|
|
2023
Q4 | $10K | Buy |
9,556
+8,226
| +618% | +$9.01K | ﹤0.01% | 7431 |
|
|
2023
Q3 | $1K | Sell |
1,330
-53
| -4% | -$72 | ﹤0.01% | 8339 |
|
|
2023
Q2 | $1K | Buy |
+1,383
| New | +$1.91K | ﹤0.01% | 8647 |
|
|
2022
Q2 | – | Sell |
-4,135
| Closed | -$5.45K | – | 10562 |
|
|
2022
Q1 | $6K | Sell |
4,135
-1,928
| -32% | -$2.99K | ﹤0.01% | 9294 |
|
|
2021
Q4 | $14K | Sell |
6,063
-45,320
| -88% | -$106K | ﹤0.01% | 8746 |
|
|
2021
Q3 | $146K | Hold |
51,383
| – | – | ﹤0.01% | 6072 |
|
|
2021
Q2 | $146K | Sell |
51,383
-20,227
| -28% | -$52.3K | ﹤0.01% | 6177 |
|
|
2021
Q1 | $168K | Buy |
+71,610
| New | +$172K | ﹤0.01% | 5015 |
|
|
2020
Q4 | – | Sell |
-13,014
| Closed | -$18.2K | – | 8736 |
|
|
2020
Q3 | $12K | Sell |
13,014
-300
| -2% | -$265 | ﹤0.01% | 6704 |
|
|
2020
Q2 | $11K | Buy |
+13,314
| New | +$11.7K | ﹤0.01% | 6598 |
|
|
2020
Q1 | – | Sell |
-85
| Closed | -$85 | – | 7943 |
|
|
2019
Q4 | $0 | Buy |
85
+12
| +16% | +$10 | ﹤0.01% | 7641 |
|
|
2019
Q3 | $0 | Sell |
73
-16,951
| -100% | -$17.6K | ﹤0.01% | 7585 |
|
|
2019
Q2 | $18K | Buy |
17,024
+470
| +3% | +$542 | ﹤0.01% | 5696 |
|
|
2019
Q1 | $21K | Buy |
16,554
+4,851
| +41% | +$6.03K | ﹤0.01% | 5687 |
|
|
2018
Q4 | $10K | Buy |
11,703
+5,796
| +98% | +$8.88K | ﹤0.01% | 5847 |
|
|
2018
Q3 | $12K | Sell |
5,907
-12,663
| -68% | -$26.6K | ﹤0.01% | 6316 |
|
|
2018
Q2 | $33K | Buy |
18,570
+7,748
| +72% | +$15.6K | ﹤0.01% | 5456 |
|
|
2018
Q1 | $25K | Sell |
10,822
-11,414
| -51% | -$26.8K | ﹤0.01% | 3126 |
|
|
2017
Q4 | $41K | Buy |
+22,236
| New | +$48.6K | ﹤0.01% | 2639 |
|
|
2017
Q3 | – | Sell |
-1,257
| Closed | -$3.12K | – | 6266 |
|
|
2017
Q2 | $3K | Sell |
1,257
-215
| -15% | -$601 | ﹤0.01% | 4970 |
|
|
2017
Q1 | $4K | Sell |
1,472
-3,742
| -72% | -$10.6K | ﹤0.01% | 4777 |
|
|
2016
Q4 | $16K | Buy |
+5,214
| New | +$16K | ﹤0.01% | 3247 |
|
|
2016
Q3 | – | Sell |
-816
| Closed | -$2.25K | – | 6145 |
|
|
2016
Q2 | $1K | Sell |
816
-6,854
| -89% | -$16.8K | ﹤0.01% | 5325 |
|
|
2016
Q1 | $19K | Buy |
+7,670
| New | +$17.1K | ﹤0.01% | 2850 |
|
|
2015
Q3 | – | Sell |
-2,279
| Closed | -$5.9K | – | 5861 |
|
|
2015
Q2 | $6K | Buy |
+2,279
| New | +$8.84K | ﹤0.01% | 3521 |
|
Other funds holding LCTX
BC
DC
RA
Simplex Trading's LCTX Position: Q2 2026 in Review
Simplex Trading sold out of Lineage Cell Therapeutics (LCTX) in Q2 2026, closing a stake of 9,698 shares — an estimated $13.4K sold.
Simplex Trading first reported a position in LCTX in Q2 2015 and held it in 31 quarters. The position peaked at $168K in Q1 2021. 132 funds tracked by Wall St. Rank hold LCTX as of Q2 2026.
- Simplex Trading reported no remaining Lineage Cell Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 9,698 Lineage Cell Therapeutics shares in Q2 2026, an estimated $13.4K.
- Simplex Trading first reported a position in Lineage Cell Therapeutics in Q2 2015 and held it in 31 quarters.
- Simplex Trading's Lineage Cell Therapeutics position peaked at $168K in Q1 2021.
- 132 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.